Business Segments Kaneka Corporation Deutsche Boerse AG

Stocks

KKA

JP3215800008

Diversified Chemicals

Delayed Deutsche Boerse AG 09:25:01 2026-09-03 EDT			5-day change	1st Jan Change
34.00 ^EUR	+3.03%		+6.25%	+32.81%

08-13	Kaneka Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027	CI
08-13	Kaneka Corporation Provides Dividend Guidance for the Second Quarter and Year-End Period of Fiscal Year Ending March 31, 2027	CI

Sales 2026 by Business Segment

Sales 2026 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (JPY)

Fiscal Period: March	2022	2023	2024	2025	2026
Plastic and Synthetic Resins
Material Solutions Unit	301B	334B	323B	343B	327B
Total Assets	276B	293B	318B	335B	345B
CAPEX	-9.4B	-10.64B	-20.51B	-23.63B	-20.39B
D&A	12.71B	13.82B	14.39B	14.9B	16.59B
Operating Income	36.38B	27.45B	27.5B	30.96B	24.93B
	-	-	-	-	75M
Quality of Life Solutions	169B	173B	176B	191B	194B
Total Assets	192B	212B	223B	221B	224B
CAPEX	-11.2B	-9.88B	-12.28B	-11.56B	-11.38B
D&A	12.37B	11.66B	11.56B	12.26B	13.13B
Operating Income	16.94B	16.13B	15.36B	20.03B	17.95B
Foamed Resin Products	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
	-	-	-	-	237M
Chemical Products	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Dairy Products and Eggs
Nutrition Solutions	163B	177B	187B	195B	206B
Total Assets	113B	120B	128B	127B	137B
CAPEX	-4.29B	-3.72B	-5.45B	-5.18B	-6.64B
D&A	5.02B	5.26B	5.45B	5.84B	5.88B
Operating Income	5.08B	7.58B	12.08B	13.07B	13.71B
	-	-	-	-	119M
Medical Equipment
Health Care Solutions Unit	58.94B	70.79B	74.86B	77.35B	83B
Total Assets	82.25B	86.85B	108B	111B	130B
CAPEX	-4.57B	-5.23B	-11.07B	-5.12B	-8.81B
D&A	4.15B	4.33B	4.8B	5.89B	6.04B
Operating Income	12.66B	15.68B	12.94B	13.4B	14.84B
	-	-	-	-	23M
Others	2.15B	2.21B	2.32B	2.33B	2.53B
Total Assets	855M	462M	521M	604M	619M
CAPEX	-41M	-101M	-18M	-26M	-26M
D&A	19M	19M	16M	15M	18M
Operating Income	501M	554M	667M	517M	551M
Unallocated Adjustment	-1.98B	-1.6B	-1.47B	-1.68B	-1.87B
CAPEX	-8.49B	-14.77B	-24.06B	-20.25B	-6.76B
D&A	3.98B	4.73B	4.96B	5.46B	5.99B
Total Assets	-295M	-32M	-1.07B	-576M	-675M
Operating Income	-17M	103M	88M	48M	84M
Operating Income	-28B	-32.42B	-36.05B	-37.98B	-39.18B
Total Assets	78.63B	81.16B	106B	139B	132B
Total Assets	-15.4B	-11.17B	-12.93B	-13.39B	-9.49B
Operating Income	7M	1M	1M	-	-
	-	-	-	-	1.42B
Polymers
Functional Resins	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Seasonings and Preservatives
Foods	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Electronic Components
Electronics	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Pharmaceutical Products
Life Science	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Textile Mill Products
Synthetic Fibers and Others	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-

Geographical breakdown of sales (JPY)

Fiscal Period: March	2022	2023	2024	2025	2026
Japan	379B	414B	427B	440B	448B
Total Assets	193B	211B	235B	243B	255B
	-	-	-	-	42.04B
Asia	142B	152B	149B	170B	163B
Total Assets	37.1B	37.28B	38.42B	37.08B	39.56B
	-	-	-	-	83.87B
Europe Etc.	73.57B	77.9B	81.81B	83.3B	83.87B
Total Assets	25.03B	27.3B	38.48B	40.15B	42.17B
	-	-	-	-	74.47B
North America	62.66B	74.62B	69.32B	77.1B	74.47B
Total Assets	16.3B	16.6B	19.85B	19.85B	19.12B
Total Assets	-	-	-	-	-
Total Assets	-	-	-	-	-
Other	34B	36.98B	34.35B	36.05B	42.04B
	-	-	-	-	163B
	-	-	-	-	448B